Total planned funding: $370,505,121
Clear active filters
Chemonics International
HTXD: Treatment: ARV Drugs
2010
2011
2012
2013
2014
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $123,165,317 |
| Zambia | $64,174,667 |
| Uganda | $43,468,836 |
| Tanzania | $28,991,257 |
| Mozambique | $25,950,448 |
| Democratic Republic of the Congo | $21,726,094 |
| Rwanda | $12,089,615 |
| Ethiopia | $11,858,985 |
| Haiti | $9,545,246 |
| Côte d'Ivoire | $6,262,838 |
| South Africa | $6,000,000 |
| Cameroon | $5,570,075 |
| Western Hemisphere Region | $4,249,880 |
| West Africa Region | $3,100,293 |
| Eswatini | $1,558,486 |
| Burundi | $952,204 |
| Namibia | $896,334 |
| Asia Regional Program | $425,000 |
| enumerations.Philippines | $358,416 |
| Malawi | $150,000 |
| Botswana | $11,130 |
Organizational Types
| Private Contractor | $370,505,121 |
Program Areas
| Treatment | $370,505,121 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $370,505,121 |